Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关实验视频

通过对抗测试视觉场的有效性.

R J Pandit, K Gales, P G Griffiths

    Lancet (London, England)
    |October 31, 2001
    PubMed
    概括
    此摘要是机器生成的。

    对抗视觉现场测试经常错过微妙的视力损失. 使用一个小红色的目标来测试中心的20度是检测视野缺陷最敏感的方法.

    科学领域:

    • 眼科医生 眼科 眼科
    • 视觉科学 视觉科学

    背景情况:

    • 对抗视觉现场测试是常见的,但缺乏标准化.
    • 细微的视野缺陷可能会被标准测试遗漏.

    相关实验视频

    相关概念视频

    您也可能阅读

    相关文章

    通过共同作者、期刊和引用图与本文相关的文章。

    排序
    Same author

    A Supranuclear Disorder of Ocular Motility as a Rare Initial Presentation of Motor Neurone Disease.

    Neuro-ophthalmology (Aeolus Press)·2016
    Same author

    The Epidemiology of Leber Hereditary Optic Neuropathy in the North East of England.

    American journal of human genetics·2016
    Same author

    Persistence of the treatment effect of idebenone in Leber's hereditary optic neuropathy.

    Brain : a journal of neurology·2013
    Same author

    Subclinical multisystem neurologic disease in "pure" OPA1 autosomal dominant optic atrophy.

    Neurology·2011
    Same author

    Pattern of retinal ganglion cell loss in dominant optic atrophy due to OPA1 mutations.

    Eye (London, England)·2011
    Same author

    Eye movement recordings to investigate a supranuclear component in chronic progressive external ophthalmoplegia: a cross-sectional study.

    The British journal of ophthalmology·2010
    Same journal

    Assisted dying and the silencing of medicine's next generation.

    Lancet (London, England)·2026
    Same journal

    Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

    Lancet (London, England)·2026
    Same journal

    Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

    Lancet (London, England)·2026
    Same journal

    [<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

    Lancet (London, England)·2026
    Same journal

    Research priorities for characterising Bundibugyo virus.

    Lancet (London, England)·2026
    Same journal

    Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

    Lancet (London, England)·2026
    查看所有相关文章